TYR and melanoma: The results also confirmed that PTS (2) exhibited tyrosinase-dependent cytotoxicity in B16BL6 melanoma cells, and that PTS (2) was taken up into cells and was metabolized several times more quickly than RES (1) in human tyrosinase-expressing 293T cells.